Studies on the pulmonary physiological effect of sympathomimetic amines in bronchial asthma.
D000328:Adult; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos; D011199:Potentiometry; D011650:Pulmonary Alveoli / Q000503:physiopathology; D012118:Resorcinols / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects*; D013147:Spirometry; D014692:Ventilation-Perfusion Ratio
D000336:Aerosols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D010919:Placebos; D012118:Resorcinols; D002245:Carbon Dioxide; D009921:Metaproterenol; D007545:Isoproterenol; D010100:Oxygen